1Fong ACO, Schatz H, McDonald HR, Burton TC, Maberley AL, Joffe L.Central retinal vein occlusion in young adults (papillophlebitis). Restina,1992;12:3-11
2Bynoe LA, Weiss JN. Retinal endovascular surgery and intravitreal triamcinolone acetonide for central vein occlusion in young adults. Am J Ophthalmol,2003; 135(3):382-384
3Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol,2002;240(9):782-783
4Ip M, Kahana A, Altaweel M. Treatment of central retinal vein occlusion with triamcinolone acetonide: an optical coherence tomography study. Semin Ophthalmol,2003; 18(2):67-73
5Hayreh SS, Klgman MR, Beri M, Kimura AE, Podhajsky P. Differentiation of ischemic from nonischemic central retinal vein occlusion during the early acute phase. Graefes Arch Clin Exp Ophthalmol,1990;228:201-217
6Paques M, Vallee JN, Herbreteau D, Aymart A, Santiago PY, Campinchi-Tardy F, Payen D, Merlan J J, Gaudric A, Massin P. Superselective ophthalmic artery fibrinolytic therapy for the treatment of central retinal vein occlusion. Br J Ophthalmol,2000;84(12 ):1387-1391
7Vallee JN, Aymard A, Paques M, Santiago PY, Gaudric A, Merland JJ. Value of local ophthalmic artery fibrinolysis in severe forms of central retinal vein occlusion.J Radiol,2001 ;82(2): 137-144
8Loren LJ, Frade G, Torrado MC, Navarro JL. Thrombus age and tissue plasminogen activator mediated thrombolysis in rats. Thromb Res,1989;56:67-76
9Holmes DR, Califf RM, Topol EJ. Lessons we have learned from the GUSTO trial.J Am Coll Cardiol,1995;25:10-17
10Lahey JM, Fong DS, Kearney J. Intravitreal tissue plasminogen activator for acute central retinal vein occlusion. Opthalmic Surg Lasers ,1999;30 (6):427-434
